Our data revealed that more than 35% of CD4+ lymphocytes in draining lymph nodes of patients with BC expressed CXCR5, potentially enabling their entry into follicles probably through interaction with its ligand, CXCL13. This evidence concerns the gene CXCR5 and breast cancer.